Biogen Drug - Search Videos

FDA approves Biogen Alzheimer's drug, first new therapy for the disease in nearly two decades

FDA approves Biogen Alzheimer's drug, first new therapy for the disease in nearly two decades

The U.S. Food and Drug Administration just approved Biogen's new Alzheimer's drug Aducanumab, a historic move as it is the first new therapy for the disease in nearly two decades. The drug will be marketed under the name Aduhelm and is expected to generate billions of dollars in revenue for Biogen.

CNBCKatie TsaiJun 7, 2021

Biogen Alzheimers Drug

First new drug for Alzheimer's in 20 years approved by FDA

First new drug for Alzheimer's in 20 years approved by FDA

FDA approves Biogen Alzheimer’s drug for first time in 18 years

FDA approves Biogen Alzheimer’s drug for first time in 18 years

Biogen to seek FDA approval for Alzheimer's drug Aducanumab

Biogen to seek FDA approval for Alzheimer's drug Aducanumab

Top videos

Biogen surges on drug trial

Biogen surges on drug trial

Biogen alzheimer's drug shows positive results

Biogen alzheimer's drug shows positive results

FDA panel finds Biogen's Alzheimer's drug fails to show effectiveness

FDA panel finds Biogen's Alzheimer's drug fails to show effectiveness

Biogen Stock Analysis

Biogen has been an 'uninvestable' stock for awhile, says Mizuho's Jared Holz

Biogen has been an 'uninvestable' stock for awhile, says Mizuho's Jared Holz

Biogen shares soar following promising Alzheimer's drug findings

Biogen shares soar following promising Alzheimer's drug findings

Investors should have known better to blame Biogen for Alzheimer's drug failure, says WSJ reporter

Investors should have known better to blame Biogen for Alzheimer's drug failure, says WSJ reporter